Antibiotic resistance crisis and the global efforts against superbugs

October 29, 2024

Join senior editor Andrea Corona and Emily Wheeler, Director of Infectious Disease Policy at the Biotechnology Innovation Organization (BIO), as they discuss the urgency of tackling antimicrobial resistance and the coordinated global efforts needed to save the struggling market of antibiotics.

Extended Release is an Off Script series to revisit conversations with our sources and explore new developments, gain deeper insights, and provide updates on the impact of their work.

Listen the podcast on Off Script: A Pharma Manufacturing Podcast

CIDRAP

Putting a face on the ‘invisible threat’ of antimicrobial resistance

Mallory Smith was a young woman who, in her own words, had "big dreams and big goals." When she was…

How the pandemic gave power to superbugs

Antibiotics cannot cure COVID. They don’t help a bit. And yet, new data shows that, during the pandemic, COVID patients…

The World Needs New Antibiotics. The Problem Is, No One Can Make Them Profitably.

The push for antibiotics to fight fast-evolving superbugs is snagging on a broken business model. Six startups have won Food and Drug…

Fighting AMR with a value and subscription model

The recent reintroduction of the Pasteur Bill seeks to address the global threat that antimicrobial-resistant (AMR) infections pose, one subscription…

Name
First Last
Email
Zipcode
Organization
Title
Email
This field is for validation purposes and should be left unchanged.

Off Script: A Pharma Manufacturing Podcast

Antibiotic resistance crisis and the global efforts against superbugs

October 29, 2024

More

CIDRAP

Putting a face on the ‘invisible threat’ of antimicrobial resistance

NPR

How the pandemic gave power to superbugs

Wall Street Journal

The World Needs New Antibiotics. The Problem Is, No One Can Make Them Profitably.

Pharmaceutical Technology

Fighting AMR with a value and subscription model

Sign up for the latest on fighting AMR